ETF Daily News logo

The Latest Headlines at ETF Daily News

Image about Cerity Partners LLC Buys 16,166 Shares of iShares U.S. Aerospace & Defense ETF (BATS:ITA)

Cerity Partners LLC Buys 16,166 Shares of iShares U.S. Aerospace & Defense ETF (BATS:ITA)

Cerity Partners LLC increased its stake in iShares U.S. Aerospace & Defense ETF (BATS:ITA – Free Report) by 315.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &... More of this article »
Image about Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 3.2%

Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 3.2%

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) shares fell 3.2% during trading on Wednesday . The company traded as low as $29.04 and last traded at $29.16. 14,973 shares changed hands during trading, a decline... More of this article »
Image about GH Research (NASDAQ:GHRS) Trading Down 3.1%

GH Research (NASDAQ:GHRS) Trading Down 3.1%

GH Research PLC (NASDAQ:GHRS – Get Free Report) traded down 3.1% during mid-day trading on Wednesday . The company traded as low as $10.54 and last traded at $10.65. 11,876 shares were traded during mid-day trading, a decline... More of this article »
Image about Forward Air (NASDAQ:FWRD)  Shares Down 3%

Forward Air (NASDAQ:FWRD) Shares Down 3%

Forward Air Co. (NASDAQ:FWRD – Get Free Report) was down 3% on Wednesday . The stock traded as low as $24.35 and last traded at $24.46. Approximately 21,310 shares changed hands during mid-day trading, a decline of 98% from the... More of this article »
Image about Applied Materials (NASDAQ:AMAT) Stock Price Down 2.9%

Applied Materials (NASDAQ:AMAT) Stock Price Down 2.9%

Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report) traded down 2.9% during mid-day trading on Wednesday . The company traded as low as $202.86 and last traded at $203.31. 840,250 shares traded hands during mid-day trading,... More of this article »
Image about Intra-Cellular Therapies (NASDAQ:ITCI) Trading Down 2.7%

Intra-Cellular Therapies (NASDAQ:ITCI) Trading Down 2.7%

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report)’s share price was down 2.7% during mid-day trading on Wednesday . The company traded as low as $76.50 and last traded at $77.66. 193,291 shares traded hands... More of this article »
Image about PayPal (NASDAQ:PYPL) Price Target Increased to $68.00 by Analysts at Sanford C. Bernstein

PayPal (NASDAQ:PYPL) Price Target Increased to $68.00 by Analysts at Sanford C. Bernstein

PayPal (NASDAQ:PYPL – Free Report) had its price objective raised by Sanford C. Bernstein from $66.00 to $68.00 in a research note released on Thursday morning, Benzinga reports. Sanford C. Bernstein currently has a market perform... More of this article »
Image about Fiverr International (NYSE:FVRR) Price Target Cut to $28.00 by Analysts at BTIG Research

Fiverr International (NYSE:FVRR) Price Target Cut to $28.00 by Analysts at BTIG Research

Fiverr International (NYSE:FVRR – Free Report) had its price target cut by BTIG Research from $30.00 to $28.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a buy rating on the... More of this article »
Image about CSX (NASDAQ:CSX) Price Target Cut to $44.00

CSX (NASDAQ:CSX) Price Target Cut to $44.00

CSX (NASDAQ:CSX – Free Report) had its target price trimmed by UBS Group from $46.00 to $44.00 in a research note released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the transportation company’s... More of this article »
Image about Carter’s (NYSE:CRI) Price Target Lowered to $64.00 at Citigroup

Carter’s (NYSE:CRI) Price Target Lowered to $64.00 at Citigroup

Carter’s (NYSE:CRI – Free Report) had its price target lowered by Citigroup from $66.00 to $64.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a sell rating on the textile... More of this article »
Image about Bio-Path’s (BPTH) “Buy” Rating Reaffirmed at Roth Mkm

Bio-Path’s (BPTH) “Buy” Rating Reaffirmed at Roth Mkm

Roth Mkm reissued their buy rating on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note published on Thursday, Benzinga reports. Roth Mkm currently has a $40.00 price objective on the stock. Separately, StockNews.com... More of this article »
Image about Vigil Neuroscience (NASDAQ:VIGL) Given “Market Outperform” Rating at JMP Securities

Vigil Neuroscience (NASDAQ:VIGL) Given “Market Outperform” Rating at JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $23.00 target price... More of this article »
Image about Werner Enterprises (NASDAQ:WERN) Price Target Cut to $39.00 by Analysts at Stifel Nicolaus

Werner Enterprises (NASDAQ:WERN) Price Target Cut to $39.00 by Analysts at Stifel Nicolaus

Werner Enterprises (NASDAQ:WERN – Free Report) had its price objective decreased by Stifel Nicolaus from $42.00 to $39.00 in a report published on Thursday morning, Benzinga reports. Stifel Nicolaus currently has a hold rating... More of this article »
Image about Semtech (NASDAQ:SMTC) Price Target Raised to $36.00 at Stifel Nicolaus

Semtech (NASDAQ:SMTC) Price Target Raised to $36.00 at Stifel Nicolaus

Semtech (NASDAQ:SMTC – Free Report) had its target price hoisted by Stifel Nicolaus from $31.00 to $36.00 in a report published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the semiconductor... More of this article »
Image about TG Therapeutics’ (TGTX) Buy Rating Reaffirmed at LADENBURG THALM/SH SH

TG Therapeutics’ (TGTX) Buy Rating Reaffirmed at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH reaffirmed their buy rating on shares of TG Therapeutics (NASDAQ:TGTX – Free Report) in a research report report published on Thursday morning, Benzinga reports. LADENBURG THALM/SH SH currently has a $39.00... More of this article »